Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003494639 | SCV004293368 | pathogenic | Thrombophilia due to protein C deficiency, autosomal dominant | 2025-01-22 | criteria provided, single submitter | clinical testing | This sequence change falls in intron 5 of the PROC gene. It does not directly change the encoded amino acid sequence of the PROC protein. It affects a nucleotide within the consensus splice site. This variant is not present in population databases (gnomAD no frequency). This variant has been observed in individual(s) with protein C deficiency (PMID: 1868249, 31254973). It has also been observed to segregate with disease in related individuals. This variant is also known as 3222 G>T. ClinVar contains an entry for this variant (Variation ID: 2734266). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. This variant disrupts the c.400+5G nucleotide in the PROC gene. Other variant(s) that disrupt this nucleotide have been determined to be pathogenic (PMID: 1868249, 2783855; internal data). This suggests that this nucleotide is clinically significant, and that variants that disrupt this position are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. |